Complementary therapies in medicine · 2025
The impact of aromatherapy with Citrus bergamia- Lavandula angustifolia essential oil and/or mindfulness-based therapy on postmenopausal health: A factorial randomized controlled trial.
СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Salehi-Pourmehr Hanieh, Mojtahedi Mandana, Asnaashari Solmaz, Farshbaf-Khalili Azizeh, Ostadrahimi Alireza
Аннотация
BACKGROUND: This study aimed to determine the effects of combined aromatherapy with lavender (Lavandula angustifolia Mill.) essential oil (LEO) and Bergamot (Citrus×bergamia (Risso) Risso & Poit) essential oil (BEO) and/or mindfulness-based therapy (MBT) on menopausal symptoms, sleep quality, and serum cortisol.
METHODS: This factorial randomized controlled trial included 132 postmenopausal 132 postmenopausal women aged 50-60 years with mild to moderate anxiety. The recruited women were divided into four groups receiving: 1) Control: Usual care + placebo, 2) Therapy: MBT + placebo, 3) Aromatherapy: LEO + BEO Aromatherapy + usual care, and 4) Therapy & Aromatherapy: MBT + LEO-BEO aromatherapy. Participants in the aromatherapy and placebo groups were instructed to apply 2-3 drops of the assigned solution to their forearm skin and inhale it three times daily for eight weeks. Weekly MBT sessions were held over two months.
RESULTS: After two months, the aromatherapy group showed reduced total scores for menopausal symptoms [adjusted mean difference (aMD) (95 % CI): -5.7 (-9.5 to -1.8)] and anxiety [aMD (95 % CI): -1.9 (-3.4 to -0.4)] compared to the control group. Sleep quality, measured by the Pittsburgh Sleep Quality Index (PSQI), improved in both the therapy [aMD (95 % CI): -2.6 (-4.2 to -1.0)] and aromatherapy [aMD (95 % CI): -1.7 (-3.3 to -0.1)] groups versus controls. However, the combined intervention showed no significant effects compared to control (p > 0.05). Serum cortisol levels did not differ significantly across groups (p > 0.05).
CONCLUSION: MBT and LEO-BEO aromatherapy demonstrated favorable outcomes in managing menopausal symptoms and sleep quality. The combination therapy did not yield additional benefits. The registration number: IRCT20131009014957N8 The registration date: 04/12/2019.
METHODS: This factorial randomized controlled trial included 132 postmenopausal 132 postmenopausal women aged 50-60 years with mild to moderate anxiety. The recruited women were divided into four groups receiving: 1) Control: Usual care + placebo, 2) Therapy: MBT + placebo, 3) Aromatherapy: LEO + BEO Aromatherapy + usual care, and 4) Therapy & Aromatherapy: MBT + LEO-BEO aromatherapy. Participants in the aromatherapy and placebo groups were instructed to apply 2-3 drops of the assigned solution to their forearm skin and inhale it three times daily for eight weeks. Weekly MBT sessions were held over two months.
RESULTS: After two months, the aromatherapy group showed reduced total scores for menopausal symptoms [adjusted mean difference (aMD) (95 % CI): -5.7 (-9.5 to -1.8)] and anxiety [aMD (95 % CI): -1.9 (-3.4 to -0.4)] compared to the control group. Sleep quality, measured by the Pittsburgh Sleep Quality Index (PSQI), improved in both the therapy [aMD (95 % CI): -2.6 (-4.2 to -1.0)] and aromatherapy [aMD (95 % CI): -1.7 (-3.3 to -0.1)] groups versus controls. However, the combined intervention showed no significant effects compared to control (p > 0.05). Serum cortisol levels did not differ significantly across groups (p > 0.05).
CONCLUSION: MBT and LEO-BEO aromatherapy demonstrated favorable outcomes in managing menopausal symptoms and sleep quality. The combination therapy did not yield additional benefits. The registration number: IRCT20131009014957N8 The registration date: 04/12/2019.